| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Advisor
1 company
Michael E Lewis last filed a Form 4 in March 2017, as Chief Scientific Advisor at TVRD. Michael E Lewis's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 314,988 shares of TVRD. The TVRD filings lean toward selling, a net 50,834 shares.
Michael E Lewis has 9 Form 4 filings on record from February 2015 to March 2017, all as Chief Scientific Advisor at Tvardi Therapeutics (TVRD), 2015–2017.
The 9 reported transactions were 7 open-market sales and 2 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 7 sales worth about $533K.
The largest open-market sale was 7,262 shares of TVRD at an average $11.66 on July 1, 2015, about $85K.
Shares as reported in the last Form 4 for each company; the most recent is from March 2017. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2016 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Advisor | Sell | 7,262 | $10.93 | $79,373.66 | -2.3% | |
| Jul 1, 2015 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Advisor | Sell | 7,262 | $11.66 | $84,674.92 | -2.2% | |
| Jun 1, 2015 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Advisor | Sell | 7,262 | $9.50 | $68,989.00 | -2.2% | |
| May 1, 2015 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Advisor | Sell | 7,262 | $10.64 | $77,267.68 | -2.1% | |
| Apr 1, 2015 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Advisor | Sell | 7,262 | $9.90 | $71,893.80 | -2.1% | |
| Mar 2, 2015 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Advisor | Sell | 7,262 | $10.11 | $73,418.82 | -2.0% | |
| Feb 2, 2015 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Advisor | Sell | 7,262 | $10.60 | $76,977.20 | -2.0% |